Impact of early gut microbiota on immune and metabolic development and function

Seminars in Fetal and Neonatal Medicine

Volumn 21, Issue 6, 2016, Pages 380-387

  Wang, Mei ^a   Monaco, Marcia H ^a   Donovan, Sharon M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antibiotics; Cesarean section; Diet; Gut microbiota; Immune system; Metabolism

Indexed keywords

ANTIBIOTIC AGENT; LEUKOCYTE ANTIGEN; PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGIC DISEASE; ANTIBIOTIC THERAPY; ARTIFICIAL MILK; ATOPOBIUM; ATOPY; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BIRTH; BREAST FEEDING; CHILD HEALTH; CORYNEBACTERIUM; CROHN DISEASE; DIET; ENVIRONMENTAL FACTOR; FEEDING; FOOD INTAKE; GENETICS; GESTATIONAL AGE; HLA GENE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFANT; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MATERNAL EXPOSURE; MATERNAL STRESS; MATERNAL WEIGHT GAIN; METABOLIC DISORDER; METABOLISM; MICROBIAL COLONIZATION; NECROTIZING ENTEROCOLITIS; NONHUMAN; OBESITY; OBSTETRIC DELIVERY; ONSET AGE; PEPTOCLOSTRIDIUM DIFFICILE; PERINATAL PERIOD; PRENATAL PERIOD; PREVOTELLA; PROPIONIBACTERIUM; REVIEW; STAPHYLOCOCCUS; ULCERATIVE COLITIS; UTERUS; VAGINAL DELIVERY; WEANING; WEIGHT GAIN; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE; MICROBIOLOGY;

GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM; INTESTINES;

EID: 84964603286     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2016.04.004     Document Type: Review

References (101)

1. [1] Li, M., Wang, M., Donovan, S.M., Early development of the gut microbiome and immune-mediated childhood disorders. Semin Reprod Med 32 (2014), 74–86.
2. [2] Collado, M.C., Isolauri, E., Laitinen, K., Salminen, S., Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr 92 (2010), 1023–1030.
3. [3] Zijlmans, M.A., Korpela, K., Riksen-Walraven, J.M., de Vos, W.M., de Weerth, C., Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53 (2015), 233–245.
4. [4] Rook, G.A., Raison, C.L., Lowry, C.A., Microbiota, immunoregulatory old friends and psychiatric disorders. Adv Exp Med Biol 817 (2014), 319–356.
5. [5] Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1031.
6. [6] Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
7. [7] Mackie, R.I., Sghir, A., Gaskins, H.R., Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69 (1999), 1035S–1045S.
8. [8] Koenig, J.E., Spor, J.A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108:Suppl. 1 (2011), 4578–4585.
9. [9] Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., Brown, P.O., Development of the human infant intestinal microbiota. PLoS Biol, 5, 2007, e177.
10. [10] Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
11. [11] Zoetendal, E., Akkermans, A., Akkermans-van Vliet, W., de Visser, J., de Vos, W., The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis 13 (2001), 129–134.
12. [12] Murphy, K., O' Shea, C.A., Ryan, C.A., Dempsey, E.M., O' Toole, P.W., Stanton, C., et al. The gut microbiota composition in dichorionic triplet sets suggests a role for host genetic factors. PLoS One, 10, 2015, e0122561.
13. [13] Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
14. [14] Salter, S.J., Cox, M.J., Turek, E.M., Calus, S.T., Cookson, W.O., Moffatt, M.F., et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol, 12, 2014, 87.
15. [15] Jiménez, E., Fernández, L., Marín, M.L., Martín, R., Odriozola, J.M., Nueno-Palop, C., et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol 51 (2005), 270–274.
16. [16] Jiménez, E., Marín, M.L., Martín, R., Odriozola, J.M., Olivares, M., Xaus, J., et al. Is meconium from healthy newborns actually sterile?. Res Microbiol 159 (2008), 187–193.
17. [17] Lahtinen, S.J., Boyle, R.J., Kivivuori, S., Oppedisano, F., Smith, K.R., Robins-Browne, R., et al. Prenatal probiotic administration can influence bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 123 (2009), 499–501.
18. [18] Fallani, M., Young, D., Scott, J., Norin, E., Amarri, S., Adam, R., et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51 (2010), 77–84.
19. [19] Aloisio, I., Mazzola, G., Corvaglia, L.T., Tonti, G., Faldella, G., Biavati, B., et al. Influence of intrapartum antibiotic prophylaxis against group B streptococcus on the early newborn gut composition and evaluation of the anti-streptococcus activity of bifidobacterium strains. Appl Microbiol Biotechnol 98 (2014), 6051–6060.
20. [20] Dominguez-Bello, M.G., Costello, E.K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107 (2010), 11971–11975.
21. [21] Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118 (2006), 511–521.
22. [22] Salminen, S., Gibson, G.R., McCartney, A.L., Isolauri, E., Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 53 (2004), 1388–1389.
23. [23] Dominguez-Bello, M.G., De Jesus-Laboy, K.M., Shen, N., Cox, L.M., Amir, A., Gonzalez, A., et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med 22 (2016), 250–253.
24. [24] Rougé, C., Goldenberg, O., Ferraris, L., Berger, B., Rochat, F., Legrand, A., et al. Investigation of the intestinal microbiota in preterm infants using different methods. Anaerobe 16 (2010), 362–370.
25. [25] Westerbeek, E.A., van den Berg, A., Lafeber, H.N., Knol, J., Fetter, W.P., van Elburg, R.M., The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 25 (2006), 361–368.
26. [26] Wang, M., Li, M., Wu, S., Lebrilla, C.B., Chapkin, R.S., Ivanov, I., et al. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. J Pediatr Gastroenterol Nutr 60 (2015), 825–833.
27. [27] Hunt, K.M., Foster, J.A., Forney, L.J., Schütte, U.M., Beck, D.L., Abdo, Z., et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One, 6, 2011, e21313.
28. [28] Jost, T., Lacroix, C., Braegger, C., Chassard, C., Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr 110 (2013), 1253–1256.
29. [29] Kunz, C., Rudloff, S., Baier, W., Klein, N., Strobel, S., Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20 (2000), 699–722.
30. [30] De Leoz, M.L., Kalanetra, K.M., Bokulich, N.A., Strum, J.S., Underwood, M.A., German, J.B., et al. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J Proteome Res 14 (2015), 491–502.
31. [31] Bode, L., Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 136 (2006), 2127–2130.
32. [32] Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 (2015), 690–703.
33. [33] Fallani, M., Amarri, S., Uusijarvi, A., Adam, R., Khanna, S., Aguilera, M., et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology 157 (2011), 1385–1389.
34. [34] De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107 (2010), 14691–14696.
35. [35] Sierra, C., Bernal, M.J., Blasco, J., Martínez, R., Dalmau, J., Ortuño, I., et al. Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial. Eur J Nutr 54 (2015), 89–99.
36. [36] Haarman, M., Knol, J., Quantitative real-time PCR assays to identify and quantify fecal bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 71 (2005), 2318–2324.
37. [37] Kitajima, H., Sumida, Y., Tanaka, R., Yuki, N., Takayama, H., Fujimura, M., Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Archs Dis Childh Fetal Neonatal Ed 76 (1997), F101–F107.
38. [38] Mah, M.W., Chin, V.I., Wong, W.S., Lay, C., Tannock, G.W., Shek, L.P., et al. Effect of a milk formula containing probiotics on the fecal microbiota of Asian infants at risk of atopic diseases. Pediatr Res 62 (2007), 674–679.
39. [39] Fouhy, F., Guinane, C.M., Hussey, S., Wall, R., Ryan, C.A., Dempsey, E.M., et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 56 (2012), 5811–5820.
40. [40] Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (2009), 313–323.
41. [41] Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31 (2009), 677–689.
42. [42] Salzman, N.H., The role of the microbiome in immune cell development. Ann Allergy Asthma Immunol 113 (2014), 593–598.
43. [43] Baba, N., Samson, S., Bourdet-Sicard, R., Rubio, M., Sarfati, M., Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol 84 (2008), 468–476.
44. [44] Zeng, H., Chi, H., Metabolic control of regulatory T cell development and function. Trends Immunol 36 (2015), 3–12.
45. [45] Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341.
46. [46] Telesford, K.M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M.A., et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and treg function. Gut Microbes 6 (2015), 234–242.
47. [47] Smith, P.M., Howitt, H.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly, M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
48. [48] Fulde, M., Hornef, M.W., Maturation of the enteric mucosal innate immune system during the postnatal period. Immunol Rev 260 (2014), 21–34.
49. [49] Wesemann, D.R., Portuguese, A.J., Meyers, R.M., Gallagher, M.P., Cluff-Jones, K., Magee, L.M., et al. Microbial colonization influences early B-lineage development in the gut lamina propria. Nature 501 (2013), 112–115.
50. [50] Inman, C.F., Laycock, G.M., Mitchard, L., et al. Neonatal colonisation expands a specific intestinal antigen-presenting cell subset prior to CD4 T-cell expansion, without altering T-cell repertoire. PLoS One, 7, 2012, e33707.
51. [51] Okogbule-Wonodi, A.C., Li, G., Anand, B., Luzina, I.G., Atamas, S.P., Blanchard, T., Human foetal intestinal fibroblasts are hyper-responsive to lipopolysaccharide stimulation. Dig Liver Dis 44 (2012), 18–23.
52. [52] Pott, J., Stockinger, S., Torow, N., Smoczek, A., Lindner, C., McInerney, G., et al. Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog, 8, 2012, e1002670.
53. [53] Tanner, S.M., Berryhill, T.F., Ellenburg, J.L., Jilling, T., Cleveland, D.S., Lorenz, R.G., et al. Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol 185 (2015), 4–16.
54. [54] Sansonetti, P.J., To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol 4 (2011), 8–14.
55. [55] Manicassamy, S., Reizis, B., Ravindran, R., Nakaya, H., Salazar-Gonzalez, R.M., Wang, Y.C., et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329 (2010), 849–853.
56. [56] Franchi, L., Kamada, N., Nakamura, Y., Burberry, A., Kuffa, P., Suzuki, S., et al. NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol 13 (2012), 449–456.
57. [57] Hull, M.A., Fisher, J.G., Gutierrez, I.M., Jones, B.A., Kang, K.H., Kenny, M., et al. Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study. J Am Coll Surg 218 (2014), 1148–1155.
58. [58] Collado, M.C., Cernada, M., Neu, J., Perez-Martinez, G., Gormaz, M., Vento, M., Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatr Res 77 (2015), 726–731.
59. [59] Coggins, S.A., Wynn, J.L., Weitkamp, J.H., Infectious causes of necrotizing enterocolitis. Clin Perinatol 42 (2015), 133–154.
60. [60] Sim, K., Shaw, A.G., Randell, P., Cox, M.J., McClure, Z.E., Li, M.S., et al. Dysbiosis anticipating necrotizing enterocolitis in very premature infants. Clin Infect Dis 60 (2015), 389–397.
61. [61] Schwiertz, A., Jacobi, M., Frick, J.S., Richter, M., Rusch, K., Kohler, H., Microbiota in pediatric inflammatory bowel disease. J Pediatr 157 (2010), 240–244.
62. [62] Molodecky, N.A., Soon, I.S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54.
63. [63] Arrieta, M.C., Stiemsma, L.T., Amenyogbe, N., Brown, E.M., Finlay, B., The intestinal microbiome in early life: health and disease. Front Immunol, 5, 2014, 427.
64. [64] Eun, C.S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I.M., et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10–/– mice. Infect Immun 82 (2014), 2239–2246.
65. [65] Kolho, K.L., Korpela, K., Jaakkola, T., Pichai, M.V., Zoetendal, E.G., Salonen, A., et al. Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am J Gastroenterol 110 (2015), 921–930.
66. [66] Serban, D.E., Microbiota in inflammatory bowel disease pathogenesis and therapy: is it all about diet?. Nutr Clin Pract 30 (2015), 760–779.
67. [67] Gevers, D., Kugathasan, S., Denson, L.A., Vazquez-Baeza, Y., Van Treuren, W., Ren, B., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
68. [68] Haberman, Y., Tickle, T.L., Dexheimer, P.J., Kim, M.O., Tang, D., Karns, R., et al. Pediatric Crohn's disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 124 (2014), 3617–3633.
69. [69] Bai, J.P., Burckart, G.J., Mulberg, A.E., Literature review of gastrointestinal physiology in the elderly, in pediatric patients, and in patients with gastrointestinal diseases. J Pharm Sci, 2015 Nov 5, 10.1002/jps.24696.
70. [70] Ringel, Y., Ringel-Kulka, T., The intestinal microbiota and irritable bowel syndrome. J Clin Gastroenterol 49:Suppl. 1 (2015), S56–S59.
71. [71] Salonen, A., de Vos, W.M., Palva, A., Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156 (2010), 3205–3215.
72. [72] Rigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H.J., Michail, S., et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107 (2012), 1740–1745.
73. [73] Rangel, I., Sundin, J., Fuentes, S., Repsilber, D., de Vos, W.M., Brummer, R.J., The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther 42 (2015), 1211–1221.
74. [74] Mallol, J., Crane, J., von Mutius, E., Odhiambo, J., Keil, U., Stewart, A., ISAAC Phase Three Study Group. The international study of asthma and allergies in childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol 41 (2013), 73–85.
75. [75] Penders, J., Gerhold, K., Thijs, C., Zimmermann, K., Wahn, U., Lau, S., et al. New insights into the hygiene hypothesis in allergic diseases: mediation of sibling and birth mode effects by the gut microbiota. Gut Microbes 5 (2014), 239–244.
76. [76] Silverberg, J.I., Association between childhood eczema and headaches: an analysis of 19 US population-based studies. J Allergy Clin Immunol, 137, 2016 492–9.e5.
77. [77] Akinbami, L.J., Moorman, J.E., Simon, A.E., Schoendorf, K.C., Trends in racial disparities for asthma outcomes among children 0 to 17 years, 2001–2010. J Allergy Clin Immunol 134 (2014), 547–553.
78. [78] Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Björkstén, B., Engstrand, L., Jenmalm, M.C., Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 129 (2012), 434–440.
79. [79] Penders, J., Gerhold, K., Stobberingh, E.E., Thijs, C., Zimmermann, K., Lau, S., et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 132 (2013), 601–607.
80. [80] Ling, Z., Li, Z., Liu, X., Cheng, Y., Luo, Y., Tong, X., et al. Altered fecal microbiota composition associated with food allergy in infants. Appl Environ Microbiol 80 (2014), 2546–2554.
81. [81] Hill, D.A., Siracusa, M.C., Abt, M.C., Kim, B.S., Kobuley, D., Kubo, M., et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 18 (2012), 538–546.
82. [82] Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20 (2014), 159–166.
83. [83] Coates, M.E., Gnotobiotic animals in research: their uses and limitations. Lab Anim 9 (1975), 275–282.
84. [84] Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101 (2004), 15718–15723.
85. [85] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
86. [86] Bergstrom, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 80 (2014), 2889–2900.
87. [87] de Goffau, M.C., Fuentes, S., van den Bogert, B., Honkanen, H., de Vos, W.M., Welling, G.W., et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57 (2014), 1569–1577.
88. [88] Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814.
89. [89] Jensen, M.D., Ryan, D.H., Apovian, C.M., Ard, J.D., Comuzzie, A.G., Donato, K.A., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the obesity society. Circulation 129:Suppl. 2 (2014), S102–S138.
90. [90] Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
91. [91] Karlsson, C.L., Onnerfalt, J., Xu, J., Molin, G., Ahrne, S., Thorngren-Jerneck, K., The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 20 (2012), 2257–2261.
92. [92] Azad, M.B., Bridgman, S.L., Becker, A.B., Kozyrskyj, A.L., Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 38 (2014), 1290–1298.
93. [93] Blustein, J., Attina, T., Liu, M., Ryan, A.M., Cox, L.M., Blaser, M.J., et al. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int J Obes (Lond) 37 (2013), 900–906.
94. [94] Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278 (2003), 11312–11319.
95. [95] Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 105 (2008), 16767–16772.
96. [96] Backhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104 (2007), 979–984.
97. [97] Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
98. [98] VanBuecken, D., Lord, S., Greenbaum, C.J., Changing the course of disease in type 1 diabetes. De Groot, L.J., Beck-Peccoz, P., Chrousos, G., et al. (eds.) Endotext, 2000, MDText.com, Inc., South Dartmouth (MA).
99. [99] King, C., Sarvetnick, N., The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One, 6, 2011, e17049.
100. [100] Sun, J., Furio, L., Mecheri, R., van der Does, A.M., Lundeberg, E., Saveanu, L., et al. Pancreatic beta-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43 (2015), 304–317.
101. [101] Mejia-Leon, M.E., Petrosino, J.F., Ajami, N.J., Dominguez-Bello, M.G., de la Barca, A.M., Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep, 4, 2014, 3814.